Stock Events

Stock Events

IO Biotech 

$0.005500
52
+$0.00+7.84% 18:15 Today

Statistics

Day High
0.0087
Day Low
0.0051
52W High
2.79
52W Low
0.001
Volume
467,311
Avg. Volume
658,427
Mkt Cap
395,719.5
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

14NovExpected
Q4 0
Q3 2025
-0.32
-0.26
-0.19
-0.13
Expected EPS
-0.324
Actual EPS
-0.13

Financials

-Profit Margin
Unprofitable
2021
2022
2023
2024
0Revenue
-95.49MNet Income

Analyst Ratings

0.50Average Price Target
The highest estimate is 0.50.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IOBTQ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
BioNTech
BNTX
Mkt Cap24.67B
BioNTech SE is a competitor because it also focuses on developing immunotherapies for cancer and other serious diseases, similar to IO Biotech's focus on novel immune-modulating cancer therapies.
Moderna
MRNA
Mkt Cap31.65B
Moderna, Inc. is involved in creating mRNA-based therapies, including cancer vaccines, which puts it in direct competition with IO Biotech's immunotherapy research.
Novavax
NVAX
Mkt Cap1.6B
Novavax, Inc. competes in the development of vaccines for serious infectious diseases but its technology and approach to stimulating immune responses can be seen as competitive to IO Biotech's work in cancer immunotherapy.
Gilead Sciences
GILD
Mkt Cap162.98B
Gilead Sciences, Inc. has a broad portfolio including oncology, making it a competitor due to its involvement in developing treatments for cancer, similar to IO Biotech's focus.
AMGEN
AMGN
Mkt Cap201.93B
Amgen Inc. is a biotechnology company with efforts in oncology and therapeutics that could compete with IO Biotech's cancer immunotherapy products.
Pfizer
PFE
Mkt Cap138.61B
Pfizer Inc. has a diverse range of biopharmaceutical products, including cancer treatments, making it a competitor in the oncology space alongside IO Biotech.
Bristol-Myers Squibb
BMY
Mkt Cap118.71B
Bristol-Myers Squibb Company is heavily involved in cancer research and drug development, positioning it as a competitor to IO Biotech in the oncology market.
Merck
MRK
Mkt Cap319.99B
Merck & Co., Inc. is a leading pharmaceutical company with a strong emphasis on cancer treatments, including immunotherapy, making it a direct competitor to IO Biotech.
Roche
RHHBY
Mkt Cap341.62B
Roche Holding AG engages in the research and development of medical drugs, including cancer immunotherapies, which competes with IO Biotech's focus area.
Astrazeneca
AZN
Mkt Cap302.65B
AstraZeneca PLC is involved in the discovery and development of new cancer treatments, including immunotherapies, making it a competitor in the same field as IO Biotech.

About

IO Biotech, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating immune-modulating cancer treatments. These therapies leverage its proprietary T-win technology platform. The company's primary investigational drug, IO102-IO103, is engineered to counteract immunosuppressive proteins such as Indoleamine 2,3-dehydrogenase (IDO) and programmed death-ligand (PD-L1). This candidate is progressing through Phase 2 clinical trials for melanoma and is also being evaluated in Phase 1 trials across a range of other cancers, including lung, head and neck, bladder, and melanoma. Additionally, IO Biotech is developing IO112, a distinct product candidate. IO112 comprises a single Arginase 1-derived peptide designed to specifically target T cells that identify epitopes originating from Arginase 1, aiming to treat various malignancies. Established in 2014, the company is headquartered in Copenhagen, Denmark.
Show more...
CEO
Country
United States
ISIN
US4497781090

Listings

OTC Link
US
IOBTQ
XNAS
US
IOBT
BOATS
BOATS
IOBT.BOATS

0 Comments

Share your thoughts

FAQ

What is IO Biotech stock price today?▼
The current price of IOBTQ is $0.01 USD — it has increased by +7.84% in the past 24 hours. Watch IO Biotech stock price performance more closely on the chart.
What is IO Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange IO Biotech stocks are traded under the ticker IOBTQ.
Is IO Biotech stock price growing?▼
IOBTQ stock has risen by +13.33% compared to the previous week, the month change is a -24.44% fall, over the last year IO Biotech has showed a -99.53% decrease.
What is IO Biotech market cap?▼
Today IO Biotech has the market capitalization of 395,719.5
What were IO Biotech earnings last quarter?▼
IOBTQ earnings for the last quarter are -0.13 USD per share, whereas the estimation was -0.32 USD resulting in a +59.88% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is IO Biotech revenue for the last year?▼
IO Biotech revenue for the last year amounts to 0 USD.
What is IO Biotech net income for the last year?▼
IOBTQ net income for the last year is -95.49M USD.
In which sector is IO Biotech located?▼
IO Biotech operates in the Other sector.
When did IO Biotech complete a stock split?▼
IO Biotech has not had any recent stock splits.
Where is IO Biotech headquartered?▼
IO Biotech is headquartered in Copenhagen, United States.